Table 4.
Medians (inter-quartile ranges) of outcome measures, before and after PBM treatment for group B (n = 6)
| On enrolment | Before PBM treatment | After 4 weeks PBM treatment | After 12 weeks PBM treatment | |
| Mobility tests | ||||
| 10MWT walk speed (m/s) | 1.21 (0.24) | 1.82 (0.30)* | 1.94 (0.28)* | 1.93 (0.27) |
| 10MWT stride length (m) | 0.52 (0.09) | 0.67(0.11) | 0.71 (0.08) | 0.70 (0.08) |
| TUG (s) | 7.9 (1.6) | 7.4 (1.4)* | 6.6 (0.8)* | 6.9 (1.1) |
| TUG motor (s) | 8.6(1.2) | 8.2 (1.4) | 7.1 (0.7) | 6.9 (1.4) |
| TUG cognitive (s) | 9.6 (1.8) | 7.5 (1.1) | 7.0 (1.3)* | 6.8 (1.3) |
| Dynamic Balance test | ||||
| Step test - affected leg (n) | 10.0 (4.3) | 14.0 (2.0)* | 15.0 (2.3) | 15.5 (4.0) |
| Step test - unaffected leg (n) | 11.5 (1.8) | 12.5 (3.3) | 15.0 (2.3) | 16.0 (5.0) |
| Cognition test | ||||
| MoCA | 26.0 (2.3) | 27.5 (2.5) | 28.0 (1.5) | 29.0 (1.5) |
| Fine Motor Skill tests | ||||
| NHPT - affected hand (s) | 24.6 (6.3) | 22.5 (7.0) | 24.0 (4.1) | 26.0 (9.7) |
| NHPT - unaffected hand (s) | 22.1 (2.1) | 25.4 (7.2) | 23.9 (4.7) | 24.0 (6.9) |
| Spiral test - dominant hand (s) | 35.2 (4.4) | 33.9 (10.9) | 27.3 (10.6) | 29.0 (6.2) |
| Static Balance tests | ||||
| TS affected leg behind (s) | 2.0 (3.0) | 5.6 (6.2) | 19.5 (24.2)* | 5.8 (10.6) |
| TS unaffected leg behind (s) | 1.0 (3.0) | 4.2 (7.0) | 3.2 (20.3) | 2.3 (13.6) |
| SLS affected leg raised (s) | 1.5 (1.8) | 1.6 (1.0) | 1.2 (1.2) | 0.8 (4.5) |
| SLS unaffected leg raised (s) | 1.0 (0.8) | 2.1 (1.8) | 0.1 (1.2) | 0.9 (4.8) |
Significant improvement in outcome measure - * p < 0.05
10MWT 10 metre walk test, TUG timed up-and-go, MoCA Montreal Cognitive Assessment, NHPT nine-hole peg test, TS tandem stance (eyes closed), SLS single leg stance (eyes closed)